Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.

Date publication

juillet 2011

Journal

Gut

Auteurs

Membres identifiés du Cancéropôle Est :
Dr OUSSALAH Abderrahim , Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/21228429

Résumé

The aim of the study was to assess whether azathioprine and antitumour necrosis factor (TNF) treatment decrease the long-term need for surgery in patients with Crohn's disease.

Mots clés

Adolescent, Adult, Azathioprine, administration & dosage, Combined Modality Therapy, methods, Crohn Disease, drug therapy, Drug Administration Schedule, Epidemiologic Methods, Female, Humans, Immunosuppressive Agents, administration & dosage, Male, Middle Aged, Prognosis, Time Factors, Tumor Necrosis Factor-alpha, antagonists & inhibitors, Young Adult

Référence

Gut. 2011 Jul;60(7):930-6